Refractory Primary Amyloidosis
2 clinical trials · Condition
◉ Watch Refractory Primary Amyloidosis
| Record | Firm | Date |
|---|---|---|
| S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis (NCT03499808) | SWOG Cancer Research Network | 2018-06-06 |
| Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis (NCT03283917) | M.D. Anderson Cancer Center | 2018-02-07 |
Track Refractory Primary Amyloidosis automatically
Every clearance here is in the API, with alerts when new ones post.